Jubilant Life Sciences Q3 profit falls 23.97pc at Rs 203.38 crore Medical Dialogues Bureau1 Feb 2020 9:45 AM IST Drug firm Jubilant Life Sciences on Friday reported a 23.97 per cent fall in consolidated net profit at Rs 203.38 crore for the third quarter ended...
NPPA fixes price of 17 formulations including BP drugs,painkillers; details Medical Dialogues Bureau31 Jan 2020 4:49 PM ISTNew Delhi : Through a recent notice, the National Pharmaceutical Pricing Authority,Ministry of Chemicals and Fertilizers,Government of India has fixed...
USFDA cautions Aurobindo Pharma's oral solids formulation facility of regulatory action MD bureau31 Jan 2020 1:29 PM ISTNEW DELHI: Drug firm Aurobindo Pharma on Thursday reported that the US health regulator has cautioned that its oral solids formulation manufacturing...
Cipla Foundation sets up dedicated state-of-the-art chemistry laboratory at IISER Pune MD bureau31 Jan 2020 1:26 PM ISTPune: In continuance of its efforts to advance quality education and promote industry-academia collaboration, the Cipla Foundation, the social...
GSK launches Iodex UltraGel Medical Dialogues Bureau31 Jan 2020 1:23 PM ISTNew Delhi – GSK announced the launch of Iodex UltraGel, a new age clinically proven gel-based body pain solution. Backed by science, the new...
Yamma buys $200-mln minority stake in Turkish drug maker Sanovel Medical Dialogues Bureau30 Jan 2020 4:15 PM ISTIstanbul: Luxembourg-based Yamma Investments agreed to buy a 30% stake in Turkish generic drug maker Sanovel for $200 million, the target company's...
Aurobindo Pharma gets official action indicated classification from USFDA for its plant Meghna A Singhania30 Jan 2020 4:14 PM ISTNew Delhi: Aurobindo Pharma has announced that the US Food and Drug Administration (FDA) classified the inspection of the company's oral solids...
Merck's antibacterial med Dificid Gets FDA nod in Pediatric Indication Medical Dialogues Bureau30 Jan 2020 3:50 PM ISTMerck & Co., Inc announced that the FDA has granted approval to its new drug application ("NDA") and a supplemental NDA (sNDA) for its...
US offers 30 Billion US dollars more market to domestic pharma cos Medical Dialogues Bureau30 Jan 2020 3:10 PM ISTMumbai : Domestic pharma companies have the potential to grow their revenue from the US by almost five times at around USD 30 billion from USD 6.5...
Alembic Pharmaceuticals gets USFDA Approval for Azithromycin Tablets Medical Dialogues Bureau29 Jan 2020 1:25 PM ISTAlembic Pharmaceuticals announces USFDA Final Approval for Azithromycin Tablets USP, 600 mg. Alembic Pharmaceuticals Limited (Alembic) has announced...
Cipla gets USFDA EIR for Invagen manufacturing facility Medical Dialogues Bureau29 Jan 2020 12:57 PM ISTNew Delhi: Homegrown pharma major Cipla on Tuesday said it has received a report from the US health regulator indicating closure of the inspection at...
UK: NICE rejects Johnson and Johnson nasal spray for depression in NHS Medical Dialogues Bureau29 Jan 2020 12:38 PM ISTThe National Institute for Health and Care Excellence (NICE), which determines if a drug is included in Britain's National Healthcare System (NHS),...
